Clinical and Genetic Features of Myotonic Dystrophy Type 2

Genetic Instabilities and Neurological Diseases

Volumn , Issue , 2006, Pages 115-129

  Margolis, Jamie M ^a   Ranum, Laura P W ^a   Day, John W ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882469953     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369462-1/50008-9     Document Type: Chapter

References (85)

1. Harper P.S. Myotonic Dystrophy 2001, Saunders, London.
2. Mankodi A., Takahashi M.P., Jiang H., Beck C.L., Bowers W.J., Moxley R.T., Cannon S.C., Thornton C.A. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell 2002, 10:35-44.
3. Ranum L.P., Day J.W. Dominantly inherited, non-coding microsatellite expansion disorders. Curr. Opin. Genet. Dev. 2002, 12:266-271.
4. Brook J.D., McCurrach M.E., Harley H.G., Buckler A.J., Church D., Aburatani H., Hunter K., Stanton V.P., Thirion J.P., Hudson T., et al. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat of the 3? end of a transcript encoding a protein kinase family member. Cell 1992, 69:385.
5. Fu Y.H., Pizzuti A., Fenwick R.G., King J., Rajnarayan S., Dunne P.W., Dubel J., Nasser G.A., Ashizawa T., de Jong P., et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992, 255:1256-1258.
6. Thornton C.A., Griggs R.C., Moxley R.T. Myotonic dystrophy with no trinucleotide repeat expansion. Ann. Neurol. 1994, 35:269-272.
7. Ricker K., Koch M.C., Lehmann-Horn F., Pongratz D., Otto M., Heine R., Moxley R.T. Proximal myotonic myopathy: A new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology 1994, 44:1448-1452.
8. Day J.W., Roelofs R., Leroy B., Pech I., Benzow K., Ranum L.P.W. Clinical and genetic characteristics of a five-generation family with a novel form of myotonic dystrophy (DM2). Neuromuscul. Disord. 1999, 9:19-27.
9. Liquori C., Ricker K., Moseley M.L., Jacobsen J.F., Kress W., Naylor S., Day J.W., Ranum L.P.W. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001, 293:864-867.
10. Steinert H. Myopathologische Beitrage 1. Uber das klinischeund anatomische Bild des Muskelschwunds der Myotoniker. Dtsch. Z. Nervenheilkd. 1909, 37:58-104.
11. Batten F., Gibb H. Myotonia atrophica. Brain 1909, 32:187-205.
12. Buxton J., Shelbourne P., Davies J., Jones C., Van Tongeren T., Aslanidis C., de Jong P., Jansen G., Anvret M., Riley B., et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 1992, 355:547-548.
13. Harley H.G., Brook J.D., Rundle S.A., Crow S., Reardon W., Buckler A.J., Harper P.S., Houseman D.E., Shaw D. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 1992, 355:545-546.
14. Mahadevan M., Tsilfidis C., Sabourin L., Shutler G., Amemiya C., Jansen G., Neville C., Narang M., Barcelo J., O'Hoy K., Leblond S., Earle-MacDonald J., De Jong P.J., Wieringa B., Koneluk R.G., et al. Myotonic dystrophy mutation: An unstable CTG repeat in the 3? untranslated region of the gene. Science 1992, 255:1253-1255.
15. Udd B., Krahe R., Wallgren-Petterson C., Falck B., Kalimo H. Proximal myotonic dystrophy-a family with autosomal domiant muscular dystrophy, cataracts, hearing loss and hypogonadism: Heterogeneity of proximal myotonic syndromes?. Neuromuscul. Disord. 1997, 7:217-228.
16. Ranum L., Rasmussen P., Benzow K., Koob M., Day J. Genetic mapping of a second myotonic dystrophy locus. Nat. Genet. 1998, 19:196-198.
17. Ricker K., Grimm T., Koch M.C., Schneider C., Kress W., Reimers C.D., Schulte-Mattler W., Mueller-Myhsok B., Toyka K.V., Mueller C.R. Linkage of proximal myotonic myopathy to chromosome 3q. Neurology 1999, 52:170-171.
18. Liquori C.L., Ikeda Y., Weatherspoon M., Ricker K., Schoser B.G., Dalton J.C., Day J.W., Ranum L.P. Myotonic dystrophy type 2: Human founder haplotype and evolutionary conservation of the repeat tract. Am. J. Hum. Genet. 2003, 73:849-862.
19. Udd B., Meola G., Krahe R., Thornton C., Ranum L.P.W., Day J., Bassez G., Ricker K. Report of the 115th ENMC workshop: DM2/PROMM and other myotonic dystrophies. 3rd Workshop. Neuromuscul. Disord. 2003, 13:589-596.
20. Chung M.-Y., Ranum L.P.W., Duvick L.A., Servadio A., Zoghbi H.Y., Orr H.T. Evidence for a mechanism predisposing to intergeneration CAG repeat instability in spinocerebellar ataxia type 1. Nat. Genet. 1993, 5:254-258.
21. Gunter C., Paradee W., Crawford D.C., Meadows K.A., Newman J., Kunst C.B., Nelson D.L., Schwartz C., Murray A., Macpherson J.N., Sherman S.L., Warren S.T. Re-examination of factors associated with expansion of CGG repeats using a single nucleotide polymorphism in FMR1. Hum. Mol. Genet. 1998, 7:1935-1946.
22. Kunst C.B., Warren S.T. Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles. Cell 1994, 77:853-861.
23. Pulst S.-M., Nechiporuk A., Nechiporuk T., Gispert S., Chen X.N., Lopes-Cendes I., Pearlman S., Starkman S., Orozco-Diaz G., Lunkes A., DeJong P., Rouleau G.A., Auburger G., Korenberg J.R., Figueroa C., Sabha S. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat. Genet. 1996, 14:269-276.
24. Day J.W., Ricker K., Jacobsen J.F., Rasmussen L.J., Dick K.A., Kress W., Schneider C., Koch M.C., Beilman G.J., Harrison A.R., Dalton J.C., Ranum L.P. Myotonic dystrophy type 2: Molecular diagnostic and clinical spectrum. Neurology 2003, 60:657-664.
25. n mutation in myotonic dystrophy type 2 (DM2). Neuromuscul. Disord. 2004, 14:274-283.
26. Schneider C., Ziegler A., Ricker K., Grimm T., Kress W., Reimers C.D., Meinck H., Reiners K., Toyka K.V. Proximal myotonic myopathy: Evidence for anticipation in families with linkage to chromosome 3q. Neurology 2000, 55:383-388.
27. Hamshere M.G., Harley H., Harper P., Brook J.D., Brookfield J.F. Myotonic dystrophy: The correlation of (CTG) repeat length in leucocytes with age at onset is significant only for patients with small expansions. J. Med. Genet. 1999, 36:59-61.
28. Schoser B.G., Kress W., Walter M.C., Halliger-Keller B., Lochmuller H., Ricker K. Homozygosity for CCTG mutation in myotonic dystrophy type 2. Brain 2004, 127:1868-1877.
29. Mathieu J., Allard P., Potvin L., Prevost C., Begin P. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 1999, 52:1658-1662.
30. Thornton C. The myotonic dystrophies. Semin. Neurol. 1999, 19:25-33.
31. Ricker K., Koch M., Lehmann-Horn F., Pongratz D., Speich N., Reiners K., Schneider C., Moxley R.T. Proximal myotonic myopathy: Clinical features of a multisystem disorder similar to myotonic dystrophy. Arch. Neurol. 1995, 52:25-31.
32. Moxley R. Proximal myotonic myopathy: Mini-review of a recently delineated clinical disorder. Neuromuscul. Disord. 1996, 6:87-93.
33. Schoser B.G., Schneider-Gold C., Kress W., Goebel H.H., Reilich P., Koch M.C., Pongratz D.E., Toyka K.V., Lochmuller H., Ricker K. Muscle pathology in 57 patients with myotonic dystrophy type 2. Muscle Nerve 2004, 29:275-281.
34. Vihola A., Bassez G., Meola G., Zhang S., Haapasalo H., Paetau A., Manicelli E., Rouche A., Hogrel J.Y., Laforet P., Maisonobe T., Pellissier J.F., Krahe R., Eymard B., Udd B. Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology 2003, 60:1854-1857.
35. Phillips M.F., Harper P.S. Cardiac disease in myotonic dystrophy. Cardiovasc. Res. 1997, 33:13-22.
36. Colleran J.A., Hawley R.J., Pinnow E.E., Kokkinos P.F., Fletcher R.D. Value of the electrocardiogram in determining cardiac events and mortality in myotonic dystrophy. Am. J. Cardiol. 1997, 80:1494-1497.
37. Savkur R.S., Philips A.V., Cooper T.A. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet. 2001, 29:40-47.
38. Savkur R.S., Philips A.V., Cooper T.A., Dalton J.C., Moseley M.L., Ranum L.P., Day J.W. Insulin receptor splicing alteration in myotonic dystrophy type 2. Am. J. Hum. Genet. 2004, 74:1309-1313.
39. aminoff M., Beckley D., McIlroy M. Autonomic function in myotonic dystrophy. Arch. Neurol. 1985, 42:16.
40. Rubinsztein J.S., Rubinsztein D.C., McKenna P.J., Goodburn S., Holland A.J. Mild myotonic dystrophy is associated with memory impairment in the context of normal general intelligence. J. Med Genet. 1997, 34:229-233.
41. Bungener C., Jouvent R., Delaporte C. Psychopathological and emotional deficits in myotonic dystrophy. J. Neurol. Neurosurg. Psychiatry 1998, 65:353-356.
42. Delaporte C. Personality patterns in patients with myotonic dystrophy. Arch. Neurol. 1998, 55:635-640.
43. Ogata A., Terae S., Fujita M., Tashiro K. Anterior temporal white matter lesions in myotonic dystrophy with intellectual impairment: An MRI and neuropathological study. Neuroradiology 1998, 40:411-415.
44. Wilson B.A., Balleny H., Patterson K., Hodges J.R. Myotonic dystrophy and progressive cognitive decline: A common condition or two separate problems?. Cortex 1999, 35:113-121.
45. Meola G., Sansone V., Perani D., Colleluori A., Cappa S., Cotelli M., Fazio F., Thornton C.A., Moxley R.T. Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy. Neurology 1999, 53:1042-1050.
46. Hund E., Jansen O., Koch M., Ricker K., Fogel W., Niedermaier N., Otto M., Kuhn E., Meinck H. Proximal myotonic myopathy with MRI white matter abnormalities of the brain. Neurology 1997, 48:33-37.
47. Jansen G., Groenen P.J.T.A., Bachner D., Jap P.H.K., Coerwinkel M., Oerlemans F., van den Broek W., Gohlsch B., Pette D., Plomp J.J., Molenaar P.C., Nederhof M.G.J., van Echted C.J.A., Dekker M., Berns A., Hameister H., Wieringa B. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nat. Genet. 1996, 13:316-324.
48. Reddy S., Smith D.B., Rich M.M., Leferovich J.M., Reilly P., Davis B.M., Tran K., Rayburn H., Bronson R., Cros D., Balice-Gordon R.J., Housman D. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat. Genet. 1996, 13:325-335.
49. Klesert T.R., Cho D.H., Clark J.I., Maylie J., Adelman J., Snider L., Yuen E.C., Soriano P., Tapscott S.J. Mice deficient in Six5 develop cataracts: Implications for myotonic dystrophy. Nat. Genet. 2000, 25:105-109.
50. Mankodi A., Logigian E., Callahan L., McClain C., White R., Henderson D., Krym M., Thornton C.A. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 2000, 289:1769-1773.
51. Tapscott S.J. Deconstructing myotonic dystrophy. Science 2000, 289:1701-1702.
52. Groenen P., Wieringa B. Expanding complexity in myotonic dystrophy. Bioessays 1998, 20:901-912.
53. Pellizzoni L., Lotti F., Maras B., Pierandrei-Amaldi P. Cellular nucleic acid binding protein binds a conserved region of the 5? UTR of Xenopus laevis ribosomal protein mRNAs. J. Mol. Biol. 1997, 267:264-275.
54. Pellizzoni L., Lotti F., Rutjes S.A., Pierandrei-Amaldi P. Involvement of the Xenopus laevis Ro60 autoantigen in the alternative interaction of La and CNBP proteins with the 5?UTR of L4 ribosomal protein mRNA. J. Mol. Biol. 1998, 281:593-608.
55. Taneja K.L., McCurrach M., Schalling M., Housman D., Singer R.H. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell Biol. 1995, 128:995-1002.
56. Amack J.D., Paguio A.P., Mahadevan M.S. Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model. Hum. Mol. Genet. 1999, 8:1975-1984.
57. Mankodi A., Urbinati C.R., Yuan Q.P., Moxley R.T., Sansone V., Krym M., Henderson D., Schalling M., Swanson M.S., Thornton C.A. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum. Mol. Gent. 2001, 10:2165-2170.
58. Fardaei M., Rogers M.T., Thorpe H.M., Larkin K., Hamshere M.G., Harper P.S., Brook J.D. Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum. Mol. Genet. 2002, 11:805-814.
59. n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res. 1996, 24:4407-4414.
60. Philips A.V., Timchenko L.T., Cooper T.A. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 1998, 280:737-741.
61. Lu X., Timchenko N.A., Timchenko L.T. Cardiac elavtype RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy. Hum. Mol. Genet. 1999, 8:53-60.
62. n expansions associated with myotonic dystrophy. EMBO J 2000, 19:4439-4448.
63. Ladd A.N., Charlet N., Cooper T.A. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol. Cell. Biol. 2001, 21:1285-1296.
64. Ladd A.N., Nguyen N.H., Malhotra K., Cooper T.A. CELF6, a member of the CELF family of RNA-binding proteins, regulates muscle-specific splicing enhancer-dependent alternative splicing. J. Biol. Chem. 2004, 279:17756-17764.
65. Charlet B.N., Savkur R.S., Singh G., Philips A.V., Grice E.A., Cooper T.A. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol. Cell 2002, 10:45-53.
66. Ladd A.N., Stenberg M.G., Swanson M.S., Cooper T.A. Dynamic balance between activation and repression regulates pre-mRNA alternative splicing during heart development. Dev. Dyn. 2005, 233:783-793.
67. Ho T.H., Bundman D., Armstrong D.L., Cooper T.A. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum. Mol. Genet. 2005, 14:1539-1547.
68. Ho T.H., Charlet B.N., Poulos M.G., Singh G., Swanson M.S., Cooper T.A. Muscleblind proteins regulate alternative splicing. EMBO J. 2004, 23:3103-3112.
69. Fardaei M., Larkin K., Brook J.D., Hamshere M.G. In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts. Nucleic Acids Res. 2001, 29:2766-2771.
70. Kanadia R.N., Johnstone K.A., Mankodi A., Lungu C., Thornton C.A., Esson D., Timmers A.M., Hauswirth W.W., Swanson M.S. A muscleblind knockout model for myotonic dystrophy. Science 2003, 302:1978-1980.
71. Ho T.H., Savkur R.S., Poulos M.G., Mancini M.A., Swanson M.S., Cooper T.A. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy. J. Cell. Sci. 2005, 118:2923-2933.
72. Cooper T.A., Ordahl C.P. A single cardiac troponin T gene generates embryonic and adult isoforms via developmentally regulated alternate splicing. J. Biol. Chem. 1985, 260:11140-11148.
73. Seidman J.G., Seidman C. The genetic basis for cardiomyopathy: From mutation identification to mechanistic paradigms. Cell 2001, 104:557-567.
74. Thierfelder L., Watkins H., MacRae C., Lamas R., McKenna W., Vosberg H.P., Seidman J.G., Seidman C.E. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere. Cell 1994, 77:701-712.
75. Moller D.E., Yokota A., Caro J.F., Flier J.S. Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol. Endocrinol. 1989, 3:1263-1269.
76. Moxley R.T., Griggs R.C., Goldblatt D. Muscle insulin resistance in myotonic dystrophy: Effect of supraphysiologic insulinization. Neurology 1980, 30:1077-1083.
77. Dutzler R., Campbell E.B., Cadene M., Chait B.T., MacKinnon R. X-ray structure of a ClC chloride channel at 3.0 A reveals the molecular basis of anion selectivity. Nature 2002, 415:287-294.
78. Grunnet M., Jespersen T., Colding-Jorgensen E., Schwartz M., Klaerke D.A., Vissing J., Olesen S.P., Duno M. Characterization of two new dominant ClC-1 channel mutations associated with myotonia. Muscle Nerve 2003, 28:722-732.
79. Sasaki R., Ito N., Shimamura M., Murakami T., Kuzuhara S., Uchino M., Uyama E. A novel CLCN1 mutation: P480T in a Japanese family with Thomsen's myotonia congenita. Muscle Nerve 2001, 24:357-363.
80. Steinmeyer K., Lorenz C., Pusch M., Koch M.C., Jentsch T.J. Multimeric structure of ClC-1 chloride channel revealed by mutations in dominant myotonia congenita (Thomsen). Embo. J. 1994, 13:737-743.
81. Buee L., Bussiere T., Buee-Scherrer V., Delacourte A., Hof P.R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 2000, 33:95-130.
82. Andreadis A., Brown W.M., Kosik K.S. Structure and novel exons of the human tau gene. Biochemistry 1992, 31:10626-10633.
83. Sergeant N., Sablonniere B., Schraen-Maschke S., Ghestem A., Maurage C.A., Wattez A., Vermersch P., Delacourte A. Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum. Mol. Genet. 2001, 10:2143-2155.
84. Buj-Bello A., Laugel V., Messaddeq N., Zahreddine H., Laporte J., Pellissier J.F., Mandel J.L. The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice. Proc. Natl. Acad. Sci. USA 2002, 99:15060-15065.
85. Filippova G.N., Thienes C.P., Penn B.H., Cho D.H., Hu Y.J., Moore J.M., Klesert T.R., Lobanenkov V.V., Tapscott S.J. CTCF-binding sites flank CTG CAG repeats and form a methylation-sensitive insulator at the DM1 locus. Nat. Genet. 2001, 28:335-343.